PMVP Stock Summary and Trading Ideas (PMV Pharmaceuticals | NASDAQ:PMVP)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

PMV Pharmaceuticals trades on the NASDAQ stock market under the symbol PMVP.

As of December 16, 2025, PMVP stock price declined to $1.18 with 129,689 million shares trading.

PMVP has a beta of 0.34, meaning it tends to be less sensitive to market movements. PMVP has a correlation of 0.01 to the broad based SPY ETF.

PMVP has a market cap of $62.79 million. This is considered a Micro Cap stock.

In the last 3 years, PMVP traded as high as $9.77 and as low as $.81.

The top ETF exchange traded funds that PMVP belongs to (by Net Assets): VTI, VXF, IWC.

PMVP has underperformed the market in the last year with a price return of -25.3% while the SPY ETF gained +13.3%. However, in the short term, PMVP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.5% vs +2.8% return in SPY. But in the last 2 weeks, PMVP shares have been beat by the market, returning -8.5% compared to an SPY return of -0.4%.

PMVP support price is $1.14 and resistance is $1.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PMVP shares will trade within this expected range on the day.